Patient Leaflet Updated 04-Dec-2024 | Wockhardt UK Ltd
Sugammadex 100 mg/ml Solution for Injection
Sugammadex 100mg/ml Solution for Injection
sugammadex
1. What Sugammadex is and what it is used for
2. What you need to know before Sugammadex is given
3. How Sugammadex is given
4. Possible side effects
5. How to store Sugammadex
6. Contents of the pack and other information
Sugammadex injection contains the active substance sugammadex. Sugammadex is considered to be a Selective Relaxant Binding Agent since it only works with specific muscle relaxants, rocuronium bromide or vecuronium bromide.
When you have some types of operations, your muscles must be completely relaxed. This makes it easier for the surgeon to do the operation. For this, the general anaesthetic you are given includes medicines to make your muscles relax. These are called muscle relaxants, and examples include rocuronium bromide and vecuronium bromide. Because these medicines also make your breathing muscles relax, you need help to breathe (artificial ventilation) during and after your operation until you can breathe on your own again.
Sugammadex is used to speed up the recovery of your muscles after an operation to allow you to breathe on your own again earlier. It does this by combining with the rocuronium bromide or vecuronium bromide in your body. It can be used in adults whenever rocuronium bromide or vecuronium bromide is used and in children and adolescents (aged 2 to 17 years) when rocuronium bromide is used for a moderate level of relaxation.
Talk to your anaesthetist before Sugammadex is given
This medicine is not recommended for infants less than 2 years of age.
Sugammadex may affect other medicines or be affected by them.
Some medicines reduce the effect of Sugammadex
In general, Sugammadex does not have an effect on laboratory tests. However, it may affect the results of a blood test for a hormone called progesterone. Talk to your doctor if your progesterone levels need to be tested on the same day you receive Sugammadex.
You may still be given Sugammadex, but you need to discuss it first.
It is not known whether sugammadex can pass into breast milk. Your anaesthetist will help you decide whether to stop breast-feeding, or whether to abstain from sugammadex therapy, considering the benefit of breast-feeding to the baby and the benefit of Sugammadex to the mother.
Sugammadex has no known influence on your ability to drive and use machines.
This medicine contains up to 9.7mg sodium (main component of cooking/table salt) in each ml.
This is equivalent to 0.5% of the recommended maximum daily dietary intake of sodium for an adult.
Sugammadex will be given to you by your anaesthetist, or under the care of your anaesthetist.
Your anaesthetist will work out the dose of Sugammadex you need based on:
The usual dose is 2-4mg per kg body weight for adults and for children and adolescents between 2-17 years old. A dose of 16mg/kg can be used in adults if urgent recovery from muscle relaxation is needed.
Sugammadex will be given to you by your anaesthetist. It is given as a single injection through an intravenous line.
As your anaesthetist will be monitoring your condition carefully, it is unlikely that you will be given too much Sugammadex. But even if this happens, it is unlikely to cause any problems.
If you have any further questions on the use of this medicine, ask your anaesthetist or other doctor.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
If these side effects occur while you are under anaesthesia, they will be seen and treated by your anaesthetist.
Common side effects (may affect up to 1 in 10 people)
Uncommon side effects (may affect up to 1 in 100 people)
Frequency not known
If you get any side effects, talk to your anaesthetist or other doctor. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
By reporting side effects you can help provide more information on the safety of this medicine.
Storage will be handled by healthcare professionals.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and on the label after ‘EXP’. The expiry date refers to the last day of that month.
Do not freeze. Keep the vial in the outer carton in order to protect from light.
After first opening and dilution, store at 2 to 8°C protected from light and use within 24 hours.
Sugammadex is a clear and colourless to slightly yellow-brown solution for injection.
It comes in two different pack sizes, containing either 10 vials with 2ml or 10 vials with 5ml solution for injection.
Not all pack sizes may be marketed.
Other formats:
To listen to or request a copy of this leaflet in Braille, large print or audio please call, free of charge: 0800 198 5000.
Please be ready to give the following information:
Product Name Reference Number
Sugammadex 100mg/ml Solution for Injection 29831/0767
This is a service provided by the Royal National Institute of Blind People.
This leaflet was last revised in 11/2024.
108724/3
Ash Road North, Wrexham Industrial Estate, Wrexham, LL13 9UF
+44 (0)1978 661 702
+44 (0)1978 661 261
www.wockhardt.co.uk